Attenuated arsenic trioxide plus ATRA therapy for newly diagnosed and relapsed APL: Long-term follow-up of the AML17 trial

NCRI AML Working Group, Nigel Russell, Alan Burnett, Robert Hills, Sophie Betteridge, Mike Dennis, Jelena Jovanovic, Richard Dillon, David Grimwade

Research output: Contribution to journalLetter

6 Citations (Scopus)
Original languageEnglish
Pages (from-to)1452-1454
Number of pages3
JournalBlood
Volume132
Issue number13
DOIs
Publication statusPublished - 27 Sep 2018

Cite this

NCRI AML Working Group, Russell, N., Burnett, A., Hills, R., Betteridge, S., Dennis, M., ... Grimwade, D. (2018). Attenuated arsenic trioxide plus ATRA therapy for newly diagnosed and relapsed APL: Long-term follow-up of the AML17 trial. Blood, 132(13), 1452-1454. https://doi.org/10.1182/blood-2018-05-851824
NCRI AML Working Group ; Russell, Nigel ; Burnett, Alan ; Hills, Robert ; Betteridge, Sophie ; Dennis, Mike ; Jovanovic, Jelena ; Dillon, Richard ; Grimwade, David. / Attenuated arsenic trioxide plus ATRA therapy for newly diagnosed and relapsed APL: Long-term follow-up of the AML17 trial. In: Blood. 2018 ; Vol. 132, No. 13. pp. 1452-1454.
@article{1e655e6035784c8bb233b01cf4e69d59,
title = "Attenuated arsenic trioxide plus ATRA therapy for newly diagnosed and relapsed APL: Long-term follow-up of the AML17 trial",
author = "{NCRI AML Working Group} and Nigel Russell and Alan Burnett and Robert Hills and Sophie Betteridge and Mike Dennis and Jelena Jovanovic and Richard Dillon and David Grimwade and S. Ali and S. Betteridge and K. Bowles and D. Bowen and P. Cahalin and J. Cavenagh and R. Clark and M. Copland and C. Craddock and D. Culligan and M. Dennis and R. Dillon and S. Freeman and R. Gale and B. Gibson and Hills, {R. K.} and A. Hunter and B. Huntly and P. Johnson and G. Jones and H. Kaur and J. Kell and R. Kelly and A. Khwaja and L. Kjeldsen and S. Knapper and P. Kottaridis and R. Lown and McMullin, {M. F.} and P. Mehta and K. Mills and M. Nikolousis and D. Richardson and N. Russell and R. Spearing and D. Taussig and E. Tholouli and I. Thomas and P. Vyas",
year = "2018",
month = "9",
day = "27",
doi = "10.1182/blood-2018-05-851824",
language = "English",
volume = "132",
pages = "1452--1454",
journal = "Blood",
issn = "0006-4971",
publisher = "AMER SOC HEMATOLOGY",
number = "13",

}

NCRI AML Working Group, Russell, N, Burnett, A, Hills, R, Betteridge, S, Dennis, M, Jovanovic, J, Dillon, R & Grimwade, D 2018, 'Attenuated arsenic trioxide plus ATRA therapy for newly diagnosed and relapsed APL: Long-term follow-up of the AML17 trial', Blood, vol. 132, no. 13, pp. 1452-1454. https://doi.org/10.1182/blood-2018-05-851824

Attenuated arsenic trioxide plus ATRA therapy for newly diagnosed and relapsed APL: Long-term follow-up of the AML17 trial. / NCRI AML Working Group; Russell, Nigel; Burnett, Alan; Hills, Robert; Betteridge, Sophie; Dennis, Mike; Jovanovic, Jelena; Dillon, Richard; Grimwade, David.

In: Blood, Vol. 132, No. 13, 27.09.2018, p. 1452-1454.

Research output: Contribution to journalLetter

TY - JOUR

T1 - Attenuated arsenic trioxide plus ATRA therapy for newly diagnosed and relapsed APL: Long-term follow-up of the AML17 trial

AU - NCRI AML Working Group

AU - Russell, Nigel

AU - Burnett, Alan

AU - Hills, Robert

AU - Betteridge, Sophie

AU - Dennis, Mike

AU - Jovanovic, Jelena

AU - Dillon, Richard

AU - Grimwade, David

AU - Ali, S.

AU - Betteridge, S.

AU - Bowles, K.

AU - Bowen, D.

AU - Cahalin, P.

AU - Cavenagh, J.

AU - Clark, R.

AU - Copland, M.

AU - Craddock, C.

AU - Culligan, D.

AU - Dennis, M.

AU - Dillon, R.

AU - Freeman, S.

AU - Gale, R.

AU - Gibson, B.

AU - Hills, R. K.

AU - Hunter, A.

AU - Huntly, B.

AU - Johnson, P.

AU - Jones, G.

AU - Kaur, H.

AU - Kell, J.

AU - Kelly, R.

AU - Khwaja, A.

AU - Kjeldsen, L.

AU - Knapper, S.

AU - Kottaridis, P.

AU - Lown, R.

AU - McMullin, M. F.

AU - Mehta, P.

AU - Mills, K.

AU - Nikolousis, M.

AU - Richardson, D.

AU - Russell, N.

AU - Spearing, R.

AU - Taussig, D.

AU - Tholouli, E.

AU - Thomas, I.

AU - Vyas, P.

PY - 2018/9/27

Y1 - 2018/9/27

UR - http://www.scopus.com/inward/record.url?scp=85054007574&partnerID=8YFLogxK

U2 - 10.1182/blood-2018-05-851824

DO - 10.1182/blood-2018-05-851824

M3 - Letter

AN - SCOPUS:85054007574

VL - 132

SP - 1452

EP - 1454

JO - Blood

JF - Blood

SN - 0006-4971

IS - 13

ER -

NCRI AML Working Group, Russell N, Burnett A, Hills R, Betteridge S, Dennis M et al. Attenuated arsenic trioxide plus ATRA therapy for newly diagnosed and relapsed APL: Long-term follow-up of the AML17 trial. Blood. 2018 Sep 27;132(13):1452-1454. https://doi.org/10.1182/blood-2018-05-851824